AU711296B2 - Process for preparing viruses and viral vectors - Google Patents

Process for preparing viruses and viral vectors Download PDF

Info

Publication number
AU711296B2
AU711296B2 AU31102/95A AU3110295A AU711296B2 AU 711296 B2 AU711296 B2 AU 711296B2 AU 31102/95 A AU31102/95 A AU 31102/95A AU 3110295 A AU3110295 A AU 3110295A AU 711296 B2 AU711296 B2 AU 711296B2
Authority
AU
Australia
Prior art keywords
adenovirus
dna
plasmid
vector
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31102/95A
Other languages
English (en)
Other versions
AU3110295A (en
Inventor
Matthew Cotten
Heike Lehrmann
Birgit Panzenbock
Thomas Von Ruden
Ernst Wagner
Kurt Zatloukal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU3110295A publication Critical patent/AU3110295A/en
Application granted granted Critical
Publication of AU711296B2 publication Critical patent/AU711296B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU31102/95A 1994-07-26 1995-07-13 Process for preparing viruses and viral vectors Ceased AU711296B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4426429A DE4426429A1 (de) 1994-07-26 1994-07-26 Verfahren zum Einführen von DNA in höhere eukaryotische Zellen
DE4426429 1994-07-26
PCT/EP1995/002737 WO1996003517A1 (fr) 1994-07-26 1995-07-13 Procede de preparation de virus et de vecteurs viraux

Publications (2)

Publication Number Publication Date
AU3110295A AU3110295A (en) 1996-02-22
AU711296B2 true AU711296B2 (en) 1999-10-07

Family

ID=6524166

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31102/95A Ceased AU711296B2 (en) 1994-07-26 1995-07-13 Process for preparing viruses and viral vectors

Country Status (9)

Country Link
EP (1) EP0774009A1 (fr)
JP (1) JPH10502822A (fr)
AU (1) AU711296B2 (fr)
CA (1) CA2194465A1 (fr)
CO (1) CO4410256A1 (fr)
DE (1) DE4426429A1 (fr)
MX (1) MX9700555A (fr)
WO (1) WO1996003517A1 (fr)
ZA (1) ZA956164B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19605279A1 (de) * 1996-02-13 1997-08-14 Hoechst Ag Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung
DE19615803A1 (de) 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
IL103059A0 (en) * 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
US5656609A (en) * 1992-09-24 1997-08-12 University Of Connecticut Method of enhancing and/or prolonging expression of gene introduced into a cell using colchicine
WO1994021808A1 (fr) * 1993-03-19 1994-09-29 Boehringer Ingelheim International Gmbh Procede de preparation de vaccins anticancereux
DE4311651A1 (de) * 1993-04-08 1994-10-13 Boehringer Ingelheim Int Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen
DE4335025A1 (de) * 1993-10-14 1995-04-20 Boehringer Ingelheim Int Endosomolytisch wirksame Partikel

Also Published As

Publication number Publication date
DE4426429A1 (de) 1996-02-01
MX9700555A (es) 1997-05-31
EP0774009A1 (fr) 1997-05-21
ZA956164B (en) 1997-02-25
JPH10502822A (ja) 1998-03-17
AU3110295A (en) 1996-02-22
CA2194465A1 (fr) 1996-02-08
WO1996003517A1 (fr) 1996-02-08
CO4410256A1 (es) 1997-01-09

Similar Documents

Publication Publication Date Title
US5856152A (en) Hybrid adenovirus-AAV vector and methods of use therefor
US7067310B2 (en) Method for the preparation of a viral vector by inter-molecular homologous recombination
ES2246533T3 (es) Fibra adenovirica modificada y adenovirus dianas.
JP3565859B2 (ja) 改良されたアデノウイルスおよびその使用法
AU759573B2 (en) Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal DNA of target cells
US6228646B1 (en) Helper-free, totally defective adenovirus for gene therapy
Fisher et al. Recombinant adeno-associated virus for muscle directed gene therapy
Fisher et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis
US6387368B1 (en) Hybrid adenovirus-AAV virus and methods of use thereof
JP2001500015A (ja) Ｔ７ポリメラーゼを利用する組換えアデノ随伴ウイルスの誘導可能な製造方法
WO2000015823A1 (fr) Adenovirus a ciblage altnernatif
WO1995026411A2 (fr) Composition et methodes d'obtention de cellules productrices de virus de recombinaison isogeniques
WO2000011149A1 (fr) Procedes de production de virus associes aux adenovirus recombinants a titre eleve
CA2257148A1 (fr) Vecteur mini-adenoviral
US6399587B1 (en) Recombinant adenoviral vectors comprising a splicing sequence
EP0181930A1 (fr) Vecteurs ltr, leurs procedes de preparation et leur utilisation
US5707865A (en) Retroviral vectors for expression in embryonic cells
JPH10501402A (ja) 肝臓特異的遺伝子治療のためのベクター
MXPA97001766A (en) Defective recombinant adenovirus with a vat iva2 inactiv
US6479290B1 (en) Chimeric adenoviral vectors
Alt et al. Liver-directed gene therapy: molecular tools and current preclinical and clinical studies
CA2194465A1 (fr) Procede de preparation de virus et de vecteurs viraux
Zhong et al. Retrovirus molecular conjugates: a novel, high transduction efficiency, potentially safety-improved, gene transfer system
CA2321215C (fr) Virus hybride adenovirus-aav et ses procedes d'utilisation
CA2203808C (fr) Virus hybride adenovirus-aav et ses procedes d'utilisation

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired